543595 EPBIO

EP Biocomposites Share Price

₹164.95 +22.75 (16%)

30 Dec, 2024 19:56

SIP TrendupStart SIP in EPBIO

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 7.08%
  • Over 3 Month -4.1%
  • Over 6 Month + 3.74%
  • Over 1 Year -12.47%
SIP Lightning

Smart Investing Starts Here Start SIP with EP Biocomposites for Steady Growth!

Invest Now

EP Biocomposites Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

EP Biocomposites Financials

EP Biocomposites Technicals

EMA & SMA

Current Price
₹164.95
+ 22.75 (16%)
pointer
  • stock-down_img
  • Bullish Moving Average 11
  • stock-up_img
  • Bearish Moving Average 5
  • 20 Day
  • ₹158.44
  • 50 Day
  • ₹163.63
  • 100 Day
  • ₹166.98
  • 200 Day
  • ₹173.35

Resistance and Support

159.57 Pivot Speed
  • R3 186.48
  • R2 175.72
  • R1 170.33
  • S1 154.18
  • S2 143.42
  • S3 138.03

What's your outlook on EP Biocomposites?

You can only vote for once

EP Biocomposites Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Half Yearly Results
2024-05-24 Audited Results
2023-11-14 Half Yearly Results
2023-05-29 Audited Results
2022-11-12 Half Yearly Results

EP Biocomposites F&O

EP Biocomposites Shareholding Pattern

No data available.

About EP Biocomposites

  • NSE Symbol
  • EPBIO
  • BSE Symbol
  • 543595
  • ISIN
  • INE0D2I01014

Similar Stocks to EP Biocomposites

EP Biocomposites FAQs

EP Biocomposites share price is ₹164 As on 30 December, 2024 | 19:42

The Market Cap of EP Biocomposites is ₹27.7 Cr As on 30 December, 2024 | 19:42

The P/E ratio of EP Biocomposites is As on 30 December, 2024 | 19:42

The PB ratio of EP Biocomposites is 2.9 As on 30 December, 2024 | 19:42

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23